Scancell Share Discussion Threads

[agema] 14/12/2017 09:20

Scancell tried to get US funding. Why has nothing come forward.? Why has no UK pharma come forward. Why only a charity interested.?

[j777j] 14/12/2017 09:18

The clueless clown is back

[agema] 14/12/2017 09:18

Miavoice,

Not win win m8. If the trial fails Scancell has very little value left.

[terror] 14/12/2017 09:15

sorry but this is not get rich quick news. It is another long and slow process similar to SCIB1.

Its the wrong platform too.

Cancer Research are doing what long suffering PI's have been doing and it will likely go the same way.

[888icb] 14/12/2017 08:30

UP 18% and number 5 on the leader board.

[888icb] 14/12/2017 08:21

Straight out of the blocks and onto the leader board. There is a lot of potential here.

[miavoce] 14/12/2017 08:12

Just need the moditope patent to be approved and we should have a very good run up on the share price

[j777j] 14/12/2017 08:08

This is huuuuuge and the first of many.

[miavoce] 14/12/2017 08:08

Looks like a great arrangement - the phsse 1/2 trial gets done at no cost and risk to Scancell but Scancell have the option to buy the rights to the data if the results are good. Win win.

[bckttsim] 14/12/2017 08:07

Market will wake up to this significant news

[miavoce] 14/12/2017 07:41

Nobody noticed the CRUK partnership news ?

[wanderer1210_0] 13/12/2017 20:54

Good grief C7, after that track you posted, why do I get a image in my mind of you and ROB-HURTS dancing cheek to cheek then stirring long fully in each other's eyes? Maybe this IPA I'm quaffing is stronger than I suspected

[goyathlay] 13/12/2017 20:47

not quite my cuppa, but the raw-boned mare has some pipes.

I did see your admirable gallows humour earlier in the day @ 18:15.

They say that laughter is the best medicine, but I am sure you feel as though you have been in the placebo group these last few years.

ATB

[chelsea35] 13/12/2017 20:10

A better version perhaps.......

[chelsea35] 13/12/2017 20:02

Goy, some great tunes, your 12.44 meaningful too.

So is this................

[oldnotwise] 13/12/2017 19:34

Goy great title hehe.... Ironic really, Poor old CK passed away the other day I remember.
Well, at least we've got the festivities to look forward to,
Merry Christmas!!!
ATB

[oldnotwise] 13/12/2017 16:55

Berm
Sadly I'm not overly concerned, it's simply the poster's ability to completely flip from one stance... No risk safe as drinking water etc. To the unbelievable (and inaccurate) statement quoted above... whilst implying that there's noone else who could possibly understand...
'Spect there'll be a reason though... hehe :-)
Makes me smile really... But Hey, Christmas is coming!!!
AIMO
ATB

[bermudashorts] 13/12/2017 16:44

Can't see all of the posts over there ONW, but I assume he means Moditope is still pre-clinical. As for SCIB I would say that it is as proven as it can possibly be in 35 patients!!

[oldnotwise] 13/12/2017 16:23

Difficult to get my head round this, but I've just been lectured in the other place by Inanaco that,

"the science is not proven ONW in fact the majority is only just getting to the clinical stage,"

Why did I think that it couldn't fail... no risk etc?

Oh well, at least there's a germ of reality beginning to infiltrate what I thought was an impenetrable mass!!!! Hehe

ATB

[the real lozan] 13/12/2017 15:17

M F F F = same old, same old
.
Has ANYONE [along with HIS SCAMMING mates} EVER turned MORE potential investors AWAY from ANY single share than InSANE-cur ???
.
IF SO....by putting potential investors OFF this share = apart from HIS LIES and FALSE CLAIMS, when examined, IF NOT, by means of HIS obnoxious EGO....InSANE-CUR ..... suffers from..... InSANE-CUR, HAS at least, SAVED those 'potential investors' quite a substantial amount of money.

[oldnotwise] 13/12/2017 12:16

Goy
Zoe Muth....
Never heard her before.... now rapidly compiling a collection!!!!
Stonking antidote to the (various) markets!
Great stuff
Thanks
ATB

[goyathlay] 13/12/2017 11:55

No Torq, doesn't apply to any specific company; it was a generic point.

Difficult to deny that AIM Companies are populated by mountebanks and purveyors of quack financial nostrums though, across all sectors. Libel laws prevent further elucidation.